ResearcherAzienda Ospedaliera Citta' della Salute e della Scienza di TorinoActive in the last 2 years
Rosella Spadi
Matched on ORCID iD 0000-0003-2589-2415; OpenAlex author ID A5057523913. Sources: OpenAlex.
Their work
- Papers
- 9
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 52
2016: 1 paper · 2017: none · 2018: none · 2019: 2 papers · 2020: 2 papers · 2021: none · 2022: none · 2023: 2 papers · 2024: 2 papers
Papers 9
- A pilot study of chlorambucil in pre-treated metastatic pancreatic adenocarcinoma patients bearing germline BRCA or other DNA damage repair system variants. Co-author DOI 10.1016/j.pan.2024.09.006↗
- In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T lymphocytes and enhances their effector r… Co-author DOI 10.3389/fimmu.2024.1427424↗
- The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/cam4.6111↗
- Circulating autoantibodies to alpha-enolase (ENO1) and far upstream element-binding protein 1 (FUBP1) are negative prognostic factors for pancreatic cancer pat… Co-author DOI 10.1007/s10238-023-01236-5↗
- In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vaccination. Co-author DOI 10.1136/jitc-2020-001071↗
- Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Pancreatic Cancer Patients. Co-author DOI 10.3390/cancers12030746↗
- Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan. Co-author DOI 10.1016/j.clcc.2019.08.004↗
- Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic Biomarkers. Co-author DOI 10.3389/fonc.2019.00115↗
- Current therapeutic strategies for advanced pancreatic cancer: A review for clinicians. Co-author DOI 10.5306/wjco.v7.i1.27↗
Closest collaborators
The 25 strongest of 52 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Francesco Novelli · 5 shared papers, 2019–2024 · strength 0.59
- Paper In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T l… DOI 10.3389/fimmu.2024.1427424↗
- Paper Circulating autoantibodies to alpha-enolase (ENO1) and far upstream element-binding protein 1 (FUBP1) are negative prog… DOI 10.1007/s10238-023-01236-5↗
- Paper Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Panc… DOI 10.3390/cancers12030746↗
- Francesca Cordero · 4 shared papers, 2019–2024 · strength 0.46
- Paper In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T l… DOI 10.3389/fimmu.2024.1427424↗
- Paper Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Panc… DOI 10.3390/cancers12030746↗
- Paper In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vacci… DOI 10.1136/jitc-2020-001071↗
- Claudia Curcio · 3 shared papers, 2020–2024 · strength 0.41
- Paper In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T l… DOI 10.3389/fimmu.2024.1427424↗
- Paper Circulating autoantibodies to alpha-enolase (ENO1) and far upstream element-binding protein 1 (FUBP1) are negative prog… DOI 10.1007/s10238-023-01236-5↗
- Paper In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vacci… DOI 10.1136/jitc-2020-001071↗
- Silvia Brugiapaglia · 2 shared papers, 2023–2024 · strength 0.32
- Paper In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T l… DOI 10.3389/fimmu.2024.1427424↗
- Paper Circulating autoantibodies to alpha-enolase (ENO1) and far upstream element-binding protein 1 (FUBP1) are negative prog… DOI 10.1007/s10238-023-01236-5↗
- Mario Scartozzi · 2 shared papers, 2023–2024 · strength 0.31
- Paper A pilot study of chlorambucil in pre-treated metastatic pancreatic adenocarcinoma patients bearing germline BRCA or oth… DOI 10.1016/j.pan.2024.09.006↗
- Paper The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic … DOI 10.1002/cam4.6111↗
- Sara Lonardi · 2 shared papers, 2023–2024 · strength 0.31
- Paper A pilot study of chlorambucil in pre-treated metastatic pancreatic adenocarcinoma patients bearing germline BRCA or oth… DOI 10.1016/j.pan.2024.09.006↗
- Paper The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic … DOI 10.1002/cam4.6111↗
- Paola Cappello · 2 shared papers, 2020–2024 · strength 0.28
- Paper In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T l… DOI 10.3389/fimmu.2024.1427424↗
- Paper In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vacci… DOI 10.1136/jitc-2020-001071↗
- Giorgia Mandili · 3 shared papers, 2019–2020 · strength 0.27
- Paper Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Panc… DOI 10.3390/cancers12030746↗
- Paper In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vacci… DOI 10.1136/jitc-2020-001071↗
- Paper Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic Biomarkers. DOI 10.3389/fonc.2019.00115↗
- Laura Follia · 3 shared papers, 2019–2020 · strength 0.27
- Paper Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Panc… DOI 10.3390/cancers12030746↗
- Paper In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vacci… DOI 10.1136/jitc-2020-001071↗
- Paper Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic Biomarkers. DOI 10.3389/fonc.2019.00115↗
- Umberto Peretti · 1 shared paper, 2024 · strength 0.18
- Marina Macchini · 1 shared paper, 2024 · strength 0.18
- Andrea Spallanzani · 1 shared paper, 2024 · strength 0.18
- Catia Carconi · 1 shared paper, 2024 · strength 0.18
- Giulia Orsi · 1 shared paper, 2024 · strength 0.18
- Ingrid Garajová · 1 shared paper, 2024 · strength 0.18
- Irene Pecora · 1 shared paper, 2024 · strength 0.18
- Luca Faloppi · 1 shared paper, 2024 · strength 0.18
- Michele Reni · 1 shared paper, 2024 · strength 0.18
- Michela Capello · 2 shared papers, 2019–2020 · strength 0.18
- Samir Hanash · 2 shared papers, 2019–2020 · strength 0.18
- Claudio De Angelis · 1 shared paper, 2023 · strength 0.14
- Elisabetta Fenocchio · 1 shared paper, 2023 · strength 0.14
- Alessandro Ferrero · 1 shared paper, 2023 · strength 0.14
- Serena Langella · 1 shared paper, 2023 · strength 0.14
- Vanja Vaccaro · 1 shared paper, 2023 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.